Impact of breast cancer care pathways and related symptoms on the return-to-work process - Archive ouverte HAL
Article Dans Une Revue European Journal of Public Health Année : 2023

Impact of breast cancer care pathways and related symptoms on the return-to-work process

Résumé

Background Breast cancer (BC) treatments and related symptoms may affect return to work (RTW). The objective of this study was investigate the impact BC care pathways (timing sequence treatments) on RTW. Methods population included working-age women with who were enrolled in French CONSTANCES cohort from 2012 2018. treatments, antidepressants/anxiolytic antalgic drug deliveries (used as proxies depression pain, respectively) statutory sick pay estimate RTW time RTW) assessed monthly using data national healthcare system database. identified analysis method. Cox models time-dependent covariates used RTW, after adjusting for age socioeconomic characteristics. Results 73.2% (231/303) returned within 2 years diagnosis. Five pathway patterns identified: (i) surgery only, (ii) radiotherapy, (iii) chemotherapy, (iv) chemotherapy (v) long-term alternative chemotherapy/radiotherapy. hazards ratios non-RTW significantly higher received chemotherapy/radiotherapy andamp
Fichier principal
Vignette du fichier
ckad160.985.pdf (82.61 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04286246 , version 1 (15-11-2023)

Identifiants

Citer

Mélanie Bertin, A.L. Rolland, Bertrand Porro, Yves Roquelaure, Sofiane Kab, et al.. Impact of breast cancer care pathways and related symptoms on the return-to-work process. European Journal of Public Health, 2023, 33 (Supplement_2), pp.ckad160.985. ⟨10.1093/eurpub/ckad160.985⟩. ⟨hal-04286246⟩
87 Consultations
33 Téléchargements

Altmetric

Partager

More